Biocon, US firm launch breast cancer drug in India
In October 2007, Abraxane was approved by the Drug Controller General of India. The approval was based on the clinical trial data that was the basis of approval in the US.
Explore Business Standard
Explore Business Standard
Associate Sponsors
Co-sponsor
In October 2007, Abraxane was approved by the Drug Controller General of India. The approval was based on the clinical trial data that was the basis of approval in the US.
First Published: Jul 18 2008 | 5:02 PM IST